Suppression of ANKRD37 and MMP9 expression may explain, at least in part, D11-mediated impaired migration of glioblastoma and pancreatic cancer cells reported previously [12] and indicates that treatment of glioblastoma cells with this compound compromises cell migration and invasion by suppressing the expression of proteins that are crucial in the metastatic process. The gene discussed is ANKRD37; the disease is glioblastoma.